See What HealthDay Can Do For You
Contact Us

Role of IGF-I Receptor in Prostate Cancer Explored

Conditional deletion of receptor associated with hyperplasia, proliferation in mouse prostate

FRIDAY, May 2 (HealthDay News) -- Work with a knockout mouse model points to a crucial role for insulin-like growth factor type I receptor (IGF-IR) signaling in prostate cancer and a growth control mechanism dependent upon IGF-IR, according to research published in the May 1 issue of Cancer Research.

Brent W. Sutherland, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues describe their work with IGF-IRloxP/loxP;ARR2PBi-Cre (IGF-IR knockout mice), IGF-IR titrated mice and IGF-IR intact control mice. They found that conditional deletion of IGF-IR leads to hyperplasia in lateral, ventral and dorsal prostate lobes, and proliferation in these lobes and the anterior lobe.

In addition, conditional deletion of IGF-IR creates age-dependent apoptosis and senescence and can increase ERK1/2 activation in the dorsal and lateral lobes. The research also points to a p53-dependent cell-specific link between IGF-IR loss and repression of phosphorylated Akt and p44/42 in the ventral prostate and activation of p44/42 in the dorsal prostate. Finally, in a p53 depletion-dependent model of multistage tumorigenesis, conditional deletion of IGF-IR doesn't inhibit progressive cancer, the authors write.

"In summary, genetically engineered mouse models are helping us to define a new paradigm for IGF-I action in the prostate gland that should further help guide translational initiatives to target the IGF-I axis in prostate and other cancers using small-molecule inhibitors and other therapeutic strategies," the authors conclude.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.